RxDoctor Payments Data

Mary Elizabeth Younger

Pediatrics · Baltimore, MDNPI 1295779304

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Pharming Healthcare, Inc. at 52.4% of the total. Among pediatrics clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$129,952in general payments, 2019–2025

Across 232 payments — averaging $560.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pharming Healthcare, Inc.$68K
  • Amgen$30K
  • CSL Behring$14K
  • Takeda Pharmaceuticals U.S.A., Inc.$10K
  • Grifols USA, LLC$7K
  • Octapharma USA, Inc.$750
  • plus $308 from 3 others

What the payments were for

  • Consulting fees$65,93951%
  • Speaking & faculty fees$41,14732%
  • Travel & lodging$18,53914%
  • Food & beverage$4,1283%
  • Education$1990%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$129,952 in reported general payments places this provider in the 95th percentile of 1,307 pediatrics providers in Maryland.

See all pediatrics providers in Maryland

Medicare billing

Part B allowed, 2024
$5,273
Medicare patients
36
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$25,285
MyrbetriqMirabegron13$6,795
Albuterol Sulfate HfaAlbuterol Sulfate24$708
Venlafaxine Hcl ErVenlafaxine Hcl16$467
Ipratropium Bromide18$421
Gabapentin25$396
Methylprednisolone36$390
Levothyroxine Sodium39$364
Azithromycin45$355
Potassium Chloride34$343
Ciprofloxacin Hcl35$312
Omeprazole13$255
Buspirone Hcl24$252
Memantine Hcl12$212
Atorvastatin Calcium34$194

Paid to pharmacies, not to this prescriber.

Other pediatrics in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →